Funding Rounds
ARTHEx Biotech Series B (2023, $46M)
ARTHEx BiotechClinical stage treatment for Myotonic Dystrophy Type 1
Summary
Stage: Series B
Raised Amount: $46.32M
Raised Date: 2023-03-01
Stage: Series B
Raised Amount: $46.32M
Raised Date: 2023-03-01
